How Often Do You Need to Take GLP-1s? Understanding Your Medication Schedule

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Most GLP-1 receptor agonists, including semaglutide and tirzepatide, are administered once weekly as injections, though oral formulations taken daily have also become available. Understanding your medication schedule is essential for consistent weight loss results and managing side effects effectively. PlexusDx provides personalized GLP-1 therapy across multiple formats to match your preferences and treatment goals.

Weekly Injection Schedule for GLP-1 Treatment

GLP-1 injectable medications operate on a once-weekly dosing protocol, meaning you inject yourself the same day each week. This schedule was chosen because the medication's active form remains in your bloodstream long enough to suppress appetite and regulate blood sugar for seven days. Patients typically select a convenient day—Monday, Wednesday, or Saturday—and maintain that consistency throughout their treatment journey.

The weekly cadence simplifies adherence compared to daily medications, reducing the number of times you must remember to take a dose. Clinical trials supporting semaglutide and tirzepatide injections show that this spacing produces steady hormone levels and predictable appetite reduction. PlexusDx's Compounded Semaglutide Injection starts at $149 per month, providing reliable weekly dosing without dose-tied price increases.

Daily Oral GLP-1 Medications and Timing Consistency

Oral semaglutide and tirzepatide tablets require daily intake, typically taken once per day on an empty stomach 30 minutes before breakfast. This daily schedule demands more frequent adherence but offers patients who dislike injections a needle-free alternative. The tablet formulation reaches peak concentrations within one to two hours and maintains therapeutic levels when dosed consistently each morning.

Oral medications may require slightly higher total doses to achieve the same effect as injections due to absorption limitations in the digestive tract. PlexusDx Oral Semaglutide starts at $249 per month, and Oral Tirzepatide at $279 per month, both reflecting daily convenience without monthly price adjustments based on dose escalation.

Dose Escalation Without Price Changes at PlexusDx

A unique PlexusDx benefit is the pricing model: your dose may need to increase over weeks or months as your body adapts, but your monthly cost remains flat. This approach removes financial barriers to finding your optimal therapeutic dose, whether you start at a microdose or progress to a higher strength. Traditional weight loss programs often charge per dose, creating perverse incentives to stay on suboptimal doses for cost reasons.

The Precision Peptide Genetic Test, available for $99 after your first month of treatment, can help predict which dose range and medication type you're most likely to respond to based on your GLP1R, GIPR, FTO, and MC4R genetic variants. This personalization may accelerate your path to an effective dose, reducing trial-and-error adjustments. PlexusDx maps 14 metabolic pathways and 150+ genetic insights to inform your therapy timeline.

Microdose vs. Standard-Dose GLP-1 Protocols

PlexusDx's Microdose GLP-1 Protocol, priced at $129 per month, begins treatment at sub-standard doses to minimize nausea and gastrointestinal side effects while your system acclimates. Microdosing typically involves lower weekly injection amounts or reduced daily tablet doses for the first 2–4 weeks, then gradual escalation every 3–7 days. This slower ramp reduces dropout rates due to tolerability issues and allows your metabolism to adjust smoothly.

Standard-dose protocols progress more rapidly, achieving therapeutic appetite suppression within 3–4 weeks. Your PlexusDx clinical team will recommend a starting pace based on your medical history, concurrent medications, and treatment goals. Regardless of entry speed, pricing remains consistent—your investment in therapy doesn't climb with dose strength.

Dual-Compound GLP-Squared Options for Advanced Results

PlexusDx offers GLP-Squared Injection, a dual-compound formulation combining semaglutide and tirzepatide in one weekly injection, starting at $249 per month. This approach may enhance metabolic benefits by engaging both GLP-1 and GIP receptors simultaneously, potentially producing superior appetite reduction and blood sugar control compared to monotherapy. Patients who plateau on single-agent therapy sometimes transition to dual-compound protocols for renewed progress.

GLP-Squared Oral, combining both compounds in tablet form, starts at $369 per month for daily dosing. The weekly injection version suits patients seeking convenience, while the oral option appeals to those who prefer tablets. Both formats maintain PlexusDx's commitment to flat monthly pricing regardless of dose adjustments, ensuring your weight loss investment remains predictable and transparent.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How often do I actually inject semaglutide or tirzepatide?

You inject once per week on a day you choose and maintain consistently throughout treatment. PlexusDx's Compounded Semaglutide Injection starts at $149 per month for this weekly schedule, with no additional costs as your dose increases over time.

What happens if I miss a weekly GLP-1 injection?

If you miss a dose, take it within two days of your scheduled day. Missing occasional doses may reduce appetite suppression temporarily but won't cause harm. Consistency is key to stable results, so setting a calendar reminder helps maintain your weekly rhythm with PlexusDx treatment.

Can I switch between injection and oral GLP-1 medications?

Yes, many patients transition between injection and oral formulations based on lifestyle changes or personal preference. PlexusDx offers Compounded Semaglutide Injection ($149/mo), Oral Semaglutide ($249/mo), Compounded Tirzepatide Injection ($249/mo), and Oral Tirzepatide ($279/mo) to match your evolving needs.

How long does it take to see results once I start GLP-1 treatment?

Most patients notice reduced appetite and early weight loss within 7–14 days of beginning semaglutide or tirzepatide. Significant weight reduction typically becomes evident by 4–8 weeks as your dose reaches therapeutic levels. PlexusDx's microdose protocol may delay visible results slightly to improve tolerability, but maintains the same flat monthly pricing.

Does the Precision Peptide Genetic Test predict my ideal dosing schedule?

The Precision Peptide Genetic Test ($99 after your first treatment month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to forecast your medication response and optimal dose range. This genetic insight may help your PlexusDx clinical team tailor your escalation pace and compound selection, though your monthly cost remains flat regardless of findings.

Why does PlexusDx charge a flat monthly price instead of flat per-compound pricing?

Flat pricing removes financial barriers to finding your optimal effective dose. Your dose may need to go up—your price won't. This model, unique to PlexusDx, encourages your clinical team to adjust therapy based on clinical needs rather than cost, ensuring you receive personalized, evidence-based treatment without surprise expense increases.

Related Reading

• Glp 1S
• Medication Glp 1
• What Genetic Factors Determine How Much Sleep You Need Each Night
• Do You Often Experience Unexplained Bloating Fatigue And Digestive Issues

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.